Acadia Healthcare (ACHC) – Analysts’ Recent Ratings Changes

Several analysts have recently updated their ratings and price targets for Acadia Healthcare (NASDAQ: ACHC):

  • 8/1/2017 – Acadia Healthcare was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “Acadia Healthcare’s second-quarter 2017 earnings surpassed the Zacks Consensus Estimate, mainly driven by an increase in same facility revenue, patient days and revenue per patient day. The company is well positioned for long-term growth on the back of its inorganic strategies. Its latest Priory acquisition has substantially enhanced its asset base, making it the largest independent provider of mental health services in the U.K. Its mixed product portfolio has helped in intensifying business risk. The company’s strong balance sheet, with increasing cash flow is another positive. Year to date, shares of Acadia Healthcare have outperformed the industry. But the company suffers from high debt, escalating interest expenses and foreign exchange fluctuation. Substantial integration risks associated with its frequent acquisitions are major headwinds.”
  • 7/31/2017 – Acadia Healthcare was downgraded by analysts at BidaskClub from a “buy” rating to a “hold” rating.
  • 7/31/2017 – Acadia Healthcare had its “buy” rating reaffirmed by analysts at Craig Hallum. They now have a $65.00 price target on the stock, up previously from $52.00.
  • 7/31/2017 – Acadia Healthcare had its price target raised by analysts at Deutsche Bank AG from $58.00 to $60.00. They now have a “buy” rating on the stock.
  • 7/31/2017 – Acadia Healthcare had its “positive” rating reaffirmed by analysts at UBS AG. They now have a $60.00 price target on the stock, up previously from $54.00.
  • 7/28/2017 – Acadia Healthcare had its price target raised by analysts at Mizuho from $57.00 to $60.00. They now have a “buy” rating on the stock.
  • 7/18/2017 – Acadia Healthcare is now covered by analysts at William Blair. They set an “outperform” rating on the stock.
  • 7/1/2017 – Acadia Healthcare was upgraded by analysts at BidaskClub from a “hold” rating to a “buy” rating.
  • 6/28/2017 – Acadia Healthcare was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $53.00 price target on the stock. According to Zacks, “Acadia Healthcare is well positioned for long term growth on the back of its inorganic strategies. The latest Priory acquisition has substantially enhanced its asset base as the largest independent provider of mental health services in the U.K. Its mixed product portfolio has helped in diversifying the business risk. Year to date, the shares of Acadia Healthcare have outperformed the Zacks Hospitals industry. But the company suffers from high debt, escalating interest expenses and foreign exchange fluctuation. It is also exposed to foreign currency fluctuation. Substantial integration risks associated with its frequent acquisitions also remain a major headwind.”

Acadia Healthcare Company, Inc. (ACHC) opened at 51.50 on Thursday. The firm has a 50-day moving average of $50.00 and a 200 day moving average of $44.52. The stock has a market capitalization of $4.53 billion, a price-to-earnings ratio of 565.93 and a beta of 1.15. Acadia Healthcare Company, Inc. has a 12-month low of $32.54 and a 12-month high of $54.73.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Thursday, July 27th. The company reported $0.66 EPS for the quarter, beating the Zacks’ consensus estimate of $0.65 by $0.01. Acadia Healthcare had a net margin of 0.30% and a return on equity of 8.69%. The company had revenue of $715.90 million for the quarter, compared to the consensus estimate of $717.38 million. During the same period in the prior year, the firm posted $0.73 EPS. The company’s quarterly revenue was down 5.4% compared to the same quarter last year. On average, analysts predict that Acadia Healthcare Company, Inc. will post $2.45 earnings per share for the current fiscal year.

In other Acadia Healthcare news, EVP Christopher L. Howard sold 16,762 shares of the stock in a transaction that occurred on Thursday, August 3rd. The shares were sold at an average price of $52.47, for a total value of $879,502.14. Following the sale, the executive vice president now directly owns 200,999 shares of the company’s stock, valued at approximately $10,546,417.53. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director William Grieco sold 2,000 shares of the stock in a transaction that occurred on Friday, June 16th. The shares were sold at an average price of $45.42, for a total transaction of $90,840.00. Following the completion of the sale, the director now directly owns 47,013 shares in the company, valued at $2,135,330.46. The disclosure for this sale can be found here. Over the last three months, insiders sold 2,136,347 shares of company stock worth $105,383,249. Insiders own 11.10% of the company’s stock.

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Receive News & Ratings for Acadia Healthcare Company Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2017 Ticker Report. Google+.